|

Preimplantation Genetic Testing (PGT) in Nigeria

modern medical research laboratory portrait of af 2026 03 16 03 23 33 utc - Nordica Fertility Centre - Top IVF Facility in Nigeria - Best IVF in Lagos, Asaba, Abuja
Advances in reproductive medicine now make it possible to learn more about the genetic health of embryos before pregnancy begins. Preimplantation Genetic Testing (PGT) is an advanced laboratory procedure performed during an In Vitro Fertilization (IVF) cycle to identify certain genetic and chromosomal abnormalities before an embryo is transferred to the uterus. By selecting embryos with the appropriate genetic profile for transfer, PGT can support informed clinical decision-making and help improve treatment planning for eligible patients.

At Nordica Fertility Centre, Preimplantation Genetic Testing is offered as part of a personalised fertility treatment plan for patients who meet specific medical indications. Our fertility specialists work closely with embryologists and genetic experts to determine whether PGT is appropriate based on your reproductive history, family history, and fertility diagnosis.

What Is Preimplantation Genetic Testing (PGT)?

Preimplantation Genetic Testing (PGT) is a specialised genetic screening procedure performed on embryos created through IVF before they are transferred into the uterus. Unlike prenatal genetic testing, which is carried out during pregnancy, PGT is performed before implantation to assess embryos for selected genetic or chromosomal abnormalities.

After fertilisation, embryos are allowed to develop in the laboratory until they reach the blastocyst stage. At this point, a small number of cells are carefully removed from the outer layer of the embryo in a process known as embryo biopsy. These cells are analysed in a specialised genetics laboratory while the embryo is safely cryopreserved until the results are available.

The purpose of PGT is not to create “perfect” embryos but to identify embryos that are less likely to be affected by certain inherited genetic conditions or chromosomal abnormalities. This information helps fertility specialists determine which embryo may be most appropriate for transfer based on the patient’s individual clinical circumstances.

Because PGT requires embryos created through IVF, patients considering this procedure will first undergo an IVF treatment cycle, which may include advanced laboratory techniques such as ICSI, IMSI, or PICSI depending on the fertility diagnosis.

Who Should Consider Preimplantation Genetic Testing?

PGT is not routinely recommended for every IVF patient. Instead, it is considered when there is a medical indication that genetic testing may improve treatment planning or reduce the likelihood of passing certain inherited conditions to a child.

Your fertility specialist may recommend PGT if you:

  • Are undergoing IVF treatment
  • Have a personal or family history of inherited genetic disorders
  • Carry a known genetic mutation that could be passed to your children
  • Have experienced recurrent pregnancy loss related to chromosomal abnormalities
  • Have experienced repeated IVF implantation failure where chromosomal abnormalities may be a contributing factor
  • Have been diagnosed with structural chromosome rearrangements such as translocations or inversions
  • Wish to reduce the likelihood of transferring embryos affected by selected genetic or chromosomal abnormalities

Before recommending PGT, your fertility specialist may advise genetic counselling to discuss the benefits, limitations, and suitability of testing based on your individual medical history.

Types of Preimplantation Genetic Testing

Several forms of Preimplantation Genetic Testing are available, each designed to identify different types of genetic abnormalities.

Preimplantation Genetic Testing for Aneuploidy (PGT-A)

PGT-A evaluates whether an embryo has the correct number of chromosomes. Human embryos normally contain 46 chromosomes, arranged in 23 pairs. Embryos with extra or missing chromosomes may have a reduced chance of implantation or may result in miscarriage or certain genetic conditions.

PGT-A helps identify embryos with a normal chromosomal complement, supporting embryo selection during IVF treatment.

Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)

PGT-M is recommended when one or both intended parents carry a known inherited genetic condition caused by a mutation in a single gene.

Examples include certain inherited blood disorders, neurological diseases, and other single-gene conditions. By testing embryos before transfer, PGT-M helps identify embryos that are unlikely to inherit the specific condition being investigated.

Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR)

PGT-SR is used for patients with structural chromosome abnormalities such as balanced translocations or inversions.

Although individuals with these chromosome rearrangements may be healthy themselves, they may produce embryos with unbalanced chromosomes, increasing the risk of miscarriage or unsuccessful pregnancy. PGT-SR assists in identifying embryos with a balanced chromosome structure for transfer.

How the PGT Process Works

Preimplantation Genetic Testing forms part of a carefully coordinated IVF treatment cycle and involves several specialised laboratory procedures.

IVF Treatment and Embryo Development

The process begins with a standard IVF cycle, during which eggs are collected from the ovaries and fertilised with sperm in the embryology laboratory. Fertilisation may be performed using conventional IVF or techniques such as Intracytoplasmic Sperm Injection (ICSI) when clinically appropriate.

The resulting embryos are cultured for approximately five to six days until they reach the blastocyst stage.

Embryo Biopsy

Once suitable blastocysts have developed, a highly skilled embryologist carefully removes a small number of cells from the outer layer of each embryo. These cells later develop into the placenta, while the embryo itself continues to develop normally after freezing.

The biopsy procedure is performed using specialised laboratory equipment designed to minimise disruption to embryo development.

Genetic Analysis

The biopsied cells are sent to a specialised genetics laboratory for detailed analysis. Depending on the type of PGT being performed, the laboratory evaluates chromosome number, structural chromosome abnormalities, or specific inherited genetic mutations.

Results are carefully reviewed before recommendations are made regarding embryo selection.

Frozen Embryo Transfer

Following the availability of genetic test results, embryos identified as suitable for transfer may be thawed and transferred during a subsequent Frozen Embryo Transfer (FET) cycle.

Your fertility specialist will discuss the findings with you and develop a personalised treatment plan based on the results.

Benefits of Preimplantation Genetic Testing

For carefully selected patients, PGT can provide valuable clinical information that supports informed treatment decisions during IVF.

Potential benefits include:

  • Supports the selection of embryos for transfer based on their genetic profile
  • Reduces the likelihood of transferring embryos affected by certain genetic abnormalities
  • May reduce the risk of miscarriage associated with chromosomal abnormalities
  • Helps patients with inherited genetic conditions reduce the risk of passing on specific disorders
  • Supports personalised IVF treatment planning
  • Provides additional information for patients with recurrent pregnancy loss or repeated IVF failure

It is important to remember that while PGT provides valuable genetic information, it cannot guarantee pregnancy or eliminate every possible genetic or developmental condition.

Why Choose Nordica Fertility Centre for PGT?

Every patient undergoes a detailed fertility assessment before treatment begins to determine whether PGT is clinically appropriate. Our team explains the purpose, benefits, and limitations of testing so patients can make informed decisions with confidence.

Because PGT is closely integrated with IVF, our multidisciplinary team carefully coordinates every stage of treatment from ovarian stimulation and embryo development to embryo biopsy, genetic testing, and frozen embryo transfer. This collaborative approach ensures continuity of care while maintaining high standards of clinical practice throughout the fertility journey.

Take the Next Step in Your Fertility Journey

If you are considering IVF and have concerns about inherited genetic conditions or chromosomal abnormalities, Preimplantation Genetic Testing may form an important part of your treatment plan.

At Nordica Fertility Centre, our experienced fertility specialists provide personalised care and advanced reproductive technologies to help you make informed decisions throughout your fertility journey.

Book a consultation today to learn whether Preimplantation Genetic Testing (PGT) is appropriate for your individual fertility treatment plan.

Frequently Asked Questions

What is Preimplantation Genetic Testing?
Preimplantation Genetic Testing (PGT) is a laboratory procedure performed during IVF to assess embryos for selected genetic or chromosomal abnormalities before embryo transfer.
No. PGT is performed before pregnancy begins, while prenatal genetic testing is carried out after pregnancy has been established.
No. PGT is recommended only when there is a medical indication, such as a family history of inherited genetic conditions, recurrent pregnancy loss, or known chromosomal abnormalities.
No. PGT helps identify embryos that are less likely to carry specific genetic or chromosomal abnormalities, but it cannot guarantee a successful pregnancy or eliminate every possible medical condition.
Embryo biopsy is performed using specialised techniques by experienced embryologists. Your fertility specialist will discuss the procedure, potential risks, and expected outcomes before treatment.
For selected patients, PGT may help optimise embryo selection and improve treatment planning. However, success depends on many factors, including age, embryo quality, overall reproductive health, and the underlying fertility diagnosis.

Take the
first step.

Because nothing compares to
the joy of holding your own baby.